Casandra A Anderson, MD
Surgical Oncology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 26 years
- University of Minnesota Medical School, 2000
Offices
1 location · California Cancer Associates for Research and Excellence Inc · 64 clinicians in this group
Hospitals listed: Clovis Community Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Anderson’s office at (559) 326-1222 to ask if they take your plan before you enroll.
California Medical Board record
Licence A95564 · Current
Licensed to practise in California · since 2020 · expires 2028-08-31 · University of Minnesota Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Surgery - Surgery
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$50,218
Medicare paid this office $50,218 for 156 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Partial removal of breast | 27 | $14,554 | $520 |
| Short return visit (20+ min) | 83 | $6,820 | $66 |
| New patient visit (60+ min) | 30 | $5,191 | $173 |
| Biopsy or removal of deep lymph nodes of underarm | 23 | $4,129 | $180 |
| Long return visit (40+ min) | 15 | $2,471 | $145 |
See all 15 services
| Partial removal of breast | 27 | $14,554 | $520 |
| Short return visit (20+ min) | 83 | $6,820 | $66 |
| New patient visit (60+ min) | 30 | $5,191 | $173 |
| Biopsy or removal of deep lymph nodes of underarm | 23 | $4,129 | $180 |
| Long return visit (40+ min) | 15 | $2,471 | $145 |
| Return visit (30+ min) | 23 | $2,245 | $90 |
| New patient visit (30+ min) | 20 | $1,803 | $90 |
| New patient visit (45+ min) | 11 | $1,481 | $135 |
| Imaging of lymph nodes during surgery | 12 | $1,234 | $103 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 35 | $456 | $12 |
| Injection of radioactive material for x-ray identification of lymph node | 22 | $270 | $12 |
| Insertion of needle into vein for collection of blood sample | 17 | $216 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 19 | $160 | $8 |
| X-ray of surgical specimen | 13 | $155 | $12 |
| Blood test, basic group of blood chemicals (calcium, total) | 14 | $124 | $8 |
Procedures Medicare counted
| Mastectomy | 28 | More than 85% of doctors who do this |
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Partial removal of breast | 21 | – | 35 | 43 | 42 | 28 |
| Removal of skin and tissue, 20.0 sq cm or less | – | 137 | – | – | – | – |
| Removal of muscle and/or tissue, 20.0 sq cm or less | – | 121 | – | – | – | – |
| Biopsy or removal of deep lymph nodes of underarm | 13 | – | 20 | 27 | 27 | 23 |
| Imaging of lymph nodes during surgery | 13 | – | 21 | 28 | 23 | 12 |
| Injection of radioactive material for x-ray identification of lymph node | – | – | 20 | 28 | 26 | 22 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
156 Original Medicare patients in 2024. Average age 74 · Also on Medicaid 28% · Health risk score 1.16. At or below the middle of the specialty; the typical surgical oncology clinician is at 1.48.
Conditions among them: High blood pressure 75% · Cancer 75% · Diabetes 35% · Chronic kidney disease 31% · Coronary heart disease 29% · Depression 17% · COPD 12% · Atrial fibrillation 12% · Heart failure 10%.
The office billed $200,009, Medicare allowed $64,552 and paid $50,218; for 436 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 156 | 436 | 74 | 1.16 | $200,009 | $50,218 |
| 2023 | 159 | 626 | 74 | 1.22 | $246,444 | $65,129 |
| 2022 | 151 | 1,032 | 73 | 1.25 | $316,428 | $83,189 |
| 2021 | 124 | 532 | 72 | 1.25 | $266,616 | $63,299 |
| 2020 | 89 | 727 | 76 | 3.55 | $227,061 | $59,843 |
| 2019 | 200 | 409 | 72 | 1.75 | $417,109 | $70,337 |
| 2018 | 109 | 211 | 71 | 1.46 | $216,478 | $36,866 |
| 2017 | 110 | 193 | 71 | 1.23 | $176,672 | $35,061 |
| 2016 | 157 | 260 | 70 | 1.41 | $160,932 | $39,201 |
| 2015 | 149 | 275 | 72 | 1.46 | $237,526 | $56,279 |
| 2014 | 143 | 286 | 71 | 1.64 | $252,062 | $60,528 |
| 2013 | 120 | 293 | 71 | 1.45 | $228,923 | $50,294 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Partial removal of breast | 41 | $21,488 | $512 |
| New patient visit (60+ min) | 38 | $6,832 | $180 |
| Short return visit (20+ min) | 76 | $6,222 | $68 |
| Biopsy or removal of deep lymph nodes of underarm | 27 | $4,941 | $183 |
| Long return visit (40+ min) | 23 | $4,122 | $142 |
| Return visit (30+ min) | 31 | $3,329 | $92 |
| New patient visit (45+ min) | 19 | $2,455 | $129 |
| Imaging of lymph nodes during surgery | 23 | $2,444 | $106 |
| New patient visit (30+ min) | 12 | $1,011 | $84 |
| Injection of radioactive material for x-ray identification of lymph node | 26 | $336 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 35 | $327 | $8 |
| Blood test, comprehensive group of blood chemicals | 25 | $279 | $10 |
| Insertion of needle into vein for collection of blood sample | 19 | $252 | $8 |
| Blood test, basic group of blood chemicals (calcium, total) | 16 | $141 | $8 |
2022: 11 services
| Partial removal of breast | 37 | $22,716 | $528 |
| New patient visit (60+ min) | 58 | $9,960 | $172 |
| Biopsy or removal of deep lymph nodes of underarm | 27 | $5,210 | $193 |
| Short return visit (20+ min) | 59 | $5,007 | $69 |
| Return visit (30+ min) | 32 | $3,997 | $102 |
| Imaging of lymph nodes during surgery | 28 | $3,071 | $110 |
| Long return visit (40+ min) | 16 | $2,870 | $144 |
| New patient visit (45+ min) | 18 | $2,350 | $131 |
| Injection of radioactive material for x-ray identification of lymph node | 28 | $374 | $13 |
| Blood test, comprehensive group of blood chemicals | 17 | $229 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 22 | $222 | $8 |
2021: 16 services
| Partial removal of breast | 34 | $18,355 | $524 |
| New patient visit (60+ min) | 51 | $9,302 | $182 |
| Insertion of central venous tube with port (5 years or older) | 18 | $4,794 | $266 |
| Biopsy or removal of deep lymph nodes of underarm | 20 | $4,052 | $203 |
| New patient visit (45+ min) | 23 | $2,955 | $128 |
| Long return visit (40+ min) | 14 | $2,283 | $152 |
| Imaging of lymph nodes during surgery | 21 | $2,258 | $108 |
| Short return visit (20+ min) | 26 | $2,234 | $77 |
| Return visit (30+ min) | 16 | $1,857 | $103 |
| New patient visit (30+ min) | 18 | $1,613 | $90 |
| New patient visit (15+ min) | 13 | $801 | $62 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 20 | $322 | $15 |
| Injection of radioactive material for x-ray identification of lymph node | 20 | $273 | $14 |
| Ultrasonic guidance for blood vessel access | 20 | $229 | $11 |
| Blood test, comprehensive group of blood chemicals | 17 | $180 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 17 | $132 | $8 |
2020: 10 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 14 | $17,217 | $185 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $7,675 | $90 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 14 | $3,426 | $122 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 25 | $2,655 | $55 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 19 | $2,393 | $70 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $2,376 | $46 |
| Application of chemical to stop tissue regrowth in wound | 11 | $1,728 | $52 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 14 | $1,326 | $55 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $792 | $72 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 14 | $528 | $31 |
2019: 7 services
| Partial removal of breast | 16 | $9,797 | $467 |
| New patient visit (60+ min) | 32 | $4,167 | $130 |
| Return visit (30+ min) | 58 | $3,338 | $51 |
| Biopsy or removal of deep lymph nodes of underarm | 13 | $2,272 | $175 |
| Long return visit (40+ min) | 19 | $1,661 | $83 |
| Imaging of lymph nodes during surgery | 13 | $1,409 | $108 |
| Short return visit (20+ min) | 34 | $1,126 | $32 |
2018: 7 services
| Partial removal of breast | 15 | $7,583 | $506 |
| Return visit (30+ min) | 36 | $2,344 | $49 |
| New patient visit (60+ min) | 18 | $2,324 | $129 |
| Biopsy or removal of deep lymph nodes of underarm | 13 | $2,146 | $165 |
| Imaging of lymph nodes during surgery | 14 | $1,432 | $102 |
| Long return visit (40+ min) | 13 | $1,120 | $86 |
| Short return visit (20+ min) | 22 | $824 | $33 |
2017: 7 services
| Partial removal of breast | 12 | $5,813 | $484 |
| Biopsy or removal of deep lymph nodes of underarm | 13 | $2,129 | $164 |
| New patient visit (60+ min) | 17 | $2,075 | $122 |
| Return visit (30+ min) | 23 | $1,497 | $60 |
| Imaging of lymph nodes during surgery | 12 | $1,221 | $102 |
| Short return visit (20+ min) | 18 | $1,008 | $56 |
| Short return visit (20+ min) | 18 | $630 | $35 |
2016: 6 services
| Short return visit (20+ min) | 52 | $3,036 | $48 |
| New patient visit (30+ min) | 26 | $2,011 | $77 |
| New patient visit (45+ min) | 14 | $1,623 | $116 |
| Return visit (30+ min) | 19 | $1,558 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,439 | $103 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $740 | $30 |
2015: 5 services
| Return visit (30+ min) | 50 | $4,478 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,974 | $104 |
| New patient visit (45+ min) | 14 | $1,649 | $118 |
| Short return visit (20+ min) | 24 | $1,563 | $54 |
| New patient visit (30+ min) | 16 | $1,205 | $75 |
2014: 7 services
| Short return visit (20+ min) | 40 | $2,534 | $51 |
| Return visit (30+ min) | 20 | $1,958 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,891 | $105 |
| New patient visit (45+ min) | 12 | $1,482 | $124 |
| New patient visit (30+ min) | 17 | $1,327 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,053 | $55 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $661 | $30 |
2013: 4 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $1,463 | $29 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,348 | $54 |
| Short return visit (20+ min) | 29 | $1,175 | $36 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $831 | $76 |
Medicaid work
$207 in 2024
Medicaid paid $207 for 118 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 118 | $207 |
| 2024 | 118 | 1 | 21 | $207 |
| 2023 | 128 | 3 | 16 | $543 |
| 2022 | 120 | 7 | 14 | $211 |
| 2021 | 25 | 2 | 13 | $52 |
| 2019 | 19 | 1 | 15 | $1,123 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 100 | $363 |
| New patient visit (45+ min) | 12 | $143 |
| Return visit (30+ min) | 16 | $38 |
2022
| Injection, propofol, 10 mg | 13 | $55 |
| Injection, dexamethasone sodium phosphate, 1 mg | 15 | $48 |
| Fentanyl citrate injection | 15 | $41 |
| Injection, ondansetron hydrochloride, per 1 mg | 13 | $32 |
| Short return visit (20+ min) | 39 | $26 |
| New patient visit (60+ min) | 13 | $7 |
| Antiemetic drug, oral, not otherwise specified | 12 | $2 |
2021
| Injection, propofol, 10 mg | 13 | $28 |
| Injection, dexamethasone sodium phosphate, 1 mg | 12 | $24 |
2019
| Hospital outpatient clinic visit for assessment and management of a patient | 19 | $1,123 |
Drugs they prescribed that Part D paid
$510
Pharmacies billed $510 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
44 generic and 0 brand-name prescriptions · $510 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 44 | 20 | None | 0% | $510 |
| 2023 | 45 | 21 | 0% (0) | None | $437 |
| 2022 | 34 | 21 | None | None | $290 |
| 2021 | 53 | 23 | None | 0% | $747 |
| 2020 | 37 | 20 | None | 70% | $9,528 |
| 2019 | 44 | 27 | None | None | $3,626 |
| 2018 | 66 | 23 | 20% (13) | None | $1,837 |
| 2017 | 82 | 39 | 32% (26) | None | $3,808 |
| 2016 | 106 | 58 | 33% (35) | None | $2,968 |
| 2015 | 126 | 61 | 53% (67) | None | $2,442 |
| 2014 | 96 | 57 | 51% (49) | None | $8,608 |
| 2013 | 88 | 33 | 28% (25) | None | $3,811 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Amoxicillin-Clavulanate Potass | 12 | $182 | $15 |
2020: 1 drug
| Santyl | 26 | $9,423 | $362 |
2017: 1 drug
| Tramadol | 11 | $37 | $3 |
2016: 3 drugs
| Raloxifene | 11 | $1,244 | $113 |
| Oxycodone-Acetaminophen | 11 | $73 | $7 |
| Tramadol | 13 | $30 | $2 |
2015: 3 drugs
| Oxycodone | 25 | $338 | $14 |
| Oxycodone-Acetaminophen | 22 | $197 | $9 |
| Tramadol | 15 | $100 | $7 |
2014: 2 drugs
| Oxycodone | 25 | $345 | $14 |
| Oxycodone-Acetaminophen | 11 | $77 | $7 |
2013: 2 drugs
| Loperamide | 14 | $207 | $15 |
| Oxycodone-Acetaminophen | 13 | $62 | $5 |
Money from drug and device companies
$82 in 2025
| 2025 | 2 | 3 | None | $82 |
| 2024 | 1 | 1 | None | $28 |
| 2023 | 3 | 3 | None | $66 |
| 2022 | 2 | 5 | None | $88 |
| 2021 | 4 | 5 | None | $73 |
| 2020 | 1 | 1 | None | $68 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| SpringWorks Therapeutics | Ogsiveo | $55 | 2 payments
|
| Spectrum Pharmaceuticals | Rolvedon | $28 | 1 payment
|
See all 3 published payments
| SpringWorks Therapeutics | Meals · 2025-06-18 | Ogsiveo | $35 |
| SpringWorks Therapeutics | Meals · 2025-02-13 | Ogsiveo | $19 |
| Spectrum Pharmaceuticals | Meals · 2025-02-11 | Rolvedon | $28 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $28
| Daiichi Sankyo | Enhertu | $28 | 1 payment
|
2023: $66
| Digestive Care | Pertzye | $25 | 1 payment
|
| Ipsen Biopharmaceuticals | Tazverik | $23 | 1 payment
|
| Gilead Sciences | Trodelvy | $18 | 1 payment
|
2022: $88
| Gilead Sciences | Trodelvy | $72 | 4 payments
|
| Tactile Systems Technology | Flexitouch Plus | $16 | 1 payment
|
2021: $73
| BeiGene USA | Brukinsa | $29 | 2 payments
|
| Acrotech Biopharma | Beleodaq | $16 | 1 payment
|
| Deciphera Pharmaceuticals | Qinlock | $14 | 1 payment
|
| Gilead Sciences | Trodelvy | $14 | 1 payment
|
2020: $68
| Amgen | None | $68 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1083773170
- Licence
- CA A95564, MN 45181California A95564: Current · expires 2028-08-31
- Trained
- University of Minnesota Medical School, 2000 · 26 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- Po Box 25100, Fresno, CA, 93729
- NPI first listed
- 2006-12-06
- NPI last updated
- 2025-10-09
- NPI record certified
- 2025-10-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1125 E Spruce Ave Ste 103, Fresno, CA, 93720